AtriCure Inc
NASDAQ:ATRC
Intrinsic Value
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. [ Read More ]
The intrinsic value of one ATRC stock under the Base Case scenario is 52.11 USD. Compared to the current market price of 23.05 USD, AtriCure Inc is Undervalued by 56%.
Valuation Backtest
AtriCure Inc
Run backtest to discover the historical profit from buying and selling ATRC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
AtriCure Inc
Current Assets | 266.2m |
Cash & Short-Term Investments | 137.3m |
Receivables | 52.5m |
Other Current Assets | 76.5m |
Non-Current Assets | 347.7m |
PP&E | 46.8m |
Intangibles | 298.8m |
Other Non-Current Assets | 2.2m |
Current Liabilities | 74.6m |
Accounts Payable | 27.4m |
Accrued Liabilities | 46.1m |
Other Current Liabilities | 1.1m |
Non-Current Liabilities | 73.2m |
Long-Term Debt | 68.7m |
Other Non-Current Liabilities | 4.5m |
Earnings Waterfall
AtriCure Inc
Revenue
|
399.2m
USD
|
Cost of Revenue
|
-98.9m
USD
|
Gross Profit
|
300.4m
USD
|
Operating Expenses
|
-327.1m
USD
|
Operating Income
|
-26.7m
USD
|
Other Expenses
|
-3.8m
USD
|
Net Income
|
-30.4m
USD
|
Free Cash Flow Analysis
AtriCure Inc
ATRC Profitability Score
Profitability Due Diligence
AtriCure Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
AtriCure Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
ATRC Solvency Score
Solvency Due Diligence
AtriCure Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
AtriCure Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATRC Price Targets Summary
AtriCure Inc
According to Wall Street analysts, the average 1-year price target for ATRC is 57.27 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.
Ownership
ATRC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ATRC Price
AtriCure Inc
Average Annual Return | 18.89% |
Standard Deviation of Annual Returns | 41.85% |
Max Drawdown | -74% |
Market Capitalization | 1.1B USD |
Shares Outstanding | 48 374 600 |
Percentage of Shares Shorted | 6.92% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 875 full-time employees. The company went IPO on 2005-08-05. The company develops, manufactures, and sells devices for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management include AtriClip System and LARIAT System.
Contact
IPO
Employees
Officers
The intrinsic value of one ATRC stock under the Base Case scenario is 52.11 USD.
Compared to the current market price of 23.05 USD, AtriCure Inc is Undervalued by 56%.